Omeprazole's Effects on Pancreatic Cancer Cells
Author Information
Author(s): Udelnow Andrej, Kreyes Andreas, Ellinger Stefan, Landfester Katharina, Walther Paul, Klapperstueck Thomas, Wohlrab Johannes, Henne-Bruns Doris, Knippschild Uwe, Würl Peter
Primary Institution: University Hospital of Ulm
Hypothesis
Omeprazole modulates autophagy and inhibits proliferation in pancreatic cancer cells.
Conclusion
Omeprazole inhibits the growth of pancreatic cancer cells and may enhance the effects of chemotherapy.
Supporting Evidence
- Omeprazole inhibited proliferation at non-toxic concentrations.
- Electron microscopy showed accumulation of autophagy markers in treated cells.
- Gene expression analysis indicated modulation of apoptosis-related genes.
Takeaway
Omeprazole, a common stomach medication, can help fight pancreatic cancer by stopping cancer cells from growing and helping other cancer drugs work better.
Methodology
The study used dose-effect curves and various assays to evaluate the effects of omeprazole on pancreatic cancer cell lines.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.05
Confidence Interval
38–45
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website